Cite

HARVARD Citation

    Parmar, D. et al. (2019). A Clinical Trial To Evaluate The Safety And Efficacy Of Saroglitazar Compared To Fenofibrate In Patients With Dyslipidemia. Atherosclerosis. pp. e35-e36. [Online]. 
  
Back to record